The largest database of trusted experimental protocols

Anti mouse igg2c hrp

Manufactured by Southern Biotech

Anti-mouse IgG2C-HRP is a laboratory reagent used in immunoassays. It is a conjugate of anti-mouse IgG2C antibodies and horseradish peroxidase (HRP), a commonly used enzyme label. This product is designed for the detection and quantification of mouse IgG2C antibodies in various research and diagnostic applications.

Automatically generated - may contain errors

6 protocols using anti mouse igg2c hrp

1

Antigen-specific antibody response analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood was collected from the retro-orbital sinus two weeks after the second immunization and sera prepared. Sera were stored at 4°C until antigen-specific antibody responses were analyzed by ELISA. Briefly, ELISA plates (Nunc, Rochester, NY) were coated with 1 μg/ml antigen in 0.1 M bicarbonate buffer and blocked with 0.1% BSA-PBS. Following washes in PBS/Tween, serially diluted serum samples were added. After incubation and further washes, either anti-mouse IgG-HRP, anti-mouse-IgG2c-HRP or anti-mouse IgG1-HRP were added (all Southern Biotech, Birmingham, AL). After incubation and washing, ABTS-H2O2 (Kirkegaard and Perry Laboratories, Gaithersburg, MD) was added to the plates to reveal any reactions, which were stopped by the addition of 0.1 N H2SO4. Plates were analyzed at 405 nm (ELX808, Bio-Tek Instruments Inc, Winooski, VT). Midpoint titers were determined as EC50 values from weighted curve fits using the GraphPad Prism package V 6.03.
+ Open protocol
+ Expand
2

Quantification of Anti-OVA Antibodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Ag-specific Abs were determined by ELISA. The anti-IgG-HRP used was anti-mouse IgG1-HRP (cat#1070-05; Southern Biotech, Birmingham, AL), anti-mouse IgG2C-HRP (cat#1079-05; Southern Biotech), and anti-mouse IgA-HRP (cat#1040-05; Southern Biotech). Total anti-OVA IgG2A, IgG1 and IgA were quantified using a mouse anti-OVA IgG2A kit (cat#3015; Chondrex, Redmond, WA), anti-OVA IgG1 kit (cat#3013; Chondrex, Redmond, WA), and anti-OVA IgA kit (cat#3018; Chondrex, Redmond, WA).
+ Open protocol
+ Expand
3

Quantification of Antibody Titers in Immunized Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibody titers for various isotypes in the sera of NP-KLH immunized mice were quantified relative to a sample pooled from sera of NP-KLH immunized mice. Nunc MaxiSorp™ plates (ThermoFisher) were coated with 1µg/ml of NP-(14)-BSA or NP-(2)-BSA (Biosearch). An initial dilution of 1:500 of the serum was prepared followed by a series of 1:5 dilutions. For the quantification of anti-ds-DNA-antibodies, high-binding half-area plates (Corning) were coated with Poly-L-lysin (Sigma-Aldrich), followed by 25 ng/ml calf thymus dsDNA (Sigma-Aldrich). An initial dilution of 1:10 of the sera was prepared, following a series of 1:2 dilutions. The following isotype-specific detection antibodies were used: donkey anti-mouse IgG-HRP (JacksonImmunoResearch), goat anti-mouse IgG1-HRP, anti-mouse IgG2b-HRP, anti-mouse IgG2c-HRP, anti-mouse IgG3-HRP, anti-mouse IgM-HRP (all from SouthernBiotech). Total quantification of IgG, was performed using a mouse-IgG-Kit (Roche) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Intranasal Vaccination Enhances Mucosal Immunity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of mice (4 per group) were intranasally vaccinated with 5μg 2′3′-cGAMP adjuvanted PspA (2μg, BEI Resources) or PspA alone(11 ). Mice were immunized twice at 14 days interval. For intranasal vaccination, animals were anesthetized using isoflurane in an E–Z Anesthesia system (Euthanex Corp, Palmer, PA). PspA, with or without 2′3-cGAMP was administered in 20μl saline. Sera, BALF, and nasal washes were collected 14 days after the last immunization. The PspA-specific Abs were determined by ELISA. Secondary Abs used were anti-mouse IgG1-HRP (Southern Biotech, cat#1070-05), anti-mouse IgG2C-HRP (Southern Biotech, cat#1079-05), and anti-mouse IgA-HRP (Southern Biotech, cat#1040-05). To determine Ag-specific Th response, splenocytes from PspA or 2′3-cGAMP + PspA immunized mice were stimulated with 5μg/ml PspA for four days in culture. Th1, Th2, and Th17 cytokines were measured in the supernatant by ELISA.
+ Open protocol
+ Expand
5

Intranasal Vaccination: PspA with CDG

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of mice (4 per group) were intranasally vaccinated with CDG (5µg, Invivogen, cat# vac-cdg) adjuvanted PspA (2µg, BEI Resources) or PspA alone 9 . Mice were immunized twice at 14 days interval. For intranasal vaccination, animals were anesthetized using isoflurane in an E-Z Anesthesia system (Euthanex Corp, Palmer, PA). PspA, with or without CDG was administered in 20µl saline. Secondary Abs used were anti-mouse IgG1-HRP (Southern Biotech, cat#1070– 05), anti-mouse IgG2C-HRP (Southern Biotech, cat#1079–05), and anti-mouse IgA-HRP (Southern Biotech, cat#1040–05).
+ Open protocol
+ Expand
6

Intranasal Vaccination: PspA with CDG

Check if the same lab product or an alternative is used in the 5 most similar protocols
Groups of mice (4 per group) were intranasally vaccinated with CDG (5µg, Invivogen, cat# vac-cdg) adjuvanted PspA (2µg, BEI Resources) or PspA alone 9 . Mice were immunized twice at 14 days interval. For intranasal vaccination, animals were anesthetized using isoflurane in an E-Z Anesthesia system (Euthanex Corp, Palmer, PA). PspA, with or without CDG was administered in 20µl saline. Secondary Abs used were anti-mouse IgG1-HRP (Southern Biotech, cat#1070– 05), anti-mouse IgG2C-HRP (Southern Biotech, cat#1079–05), and anti-mouse IgA-HRP (Southern Biotech, cat#1040–05).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!